Popular Articles

Sen. Baucus Says Health Care Overhaul Will Cover About 95% Of Citizens, Will Not Cover Undocumented Immigrants
Senate Finance Committee Chair Max Baucus (D-Mont.) on Thursday said that Congress" health care overhaul plan would cover 94% to 96% of the population but not undocumented immigrants, the AP/Las Vegas Sun reports (Alonso-Zaldivar, AP/Las Vegas Sun, 5/21). In remarks at a briefing sponsored by the Kaiser Family Foundation, Families USA and the National Federation of Independent Business, Baucus said, "There are always going to be some people ... you just can"t find" to enroll, adding that "we"re going to try to get as close as we can (to 100% coverage) and we"re working hard to accomplish that." He added, "[W]e"re not going to cover undocumented workers. That"s too politically explosive" (Reichard, CQ HealthBeat, 5/21). According to an analysis by the Center for Immigration Studies and the U.S. Census Bureau, undocumented immigrants make up between 15% and 22% of the estimated 47 million U.S. residents without health coverage. Baucus said, "I don"t have a good answer yet to undocumented workers, illegal aliens," adding, "There will still be charity care " (Landers, Dallas Morning News, 5/22). Baucus said that the bill his committee is working on and that he expects to mark up in mid-June will include "incentives" and possibly requirements for employers to pay for employee health insurance. Baucus mentioned the possibility of including an individual mandate and establishing a health insurance exchange (AP/Las Vegas Sun, 5/21). Baucus also noted that the plan most likely will include a public health insurance option in some form (Tumulty, "Swampland," Time Magazine, 5/21). "Everything"s on the table," Baucus said, warning that "because this is so big, so complex, there are going to be a lot of trade-offs. ... This is just so large" (CQ HealthBeat, 5/21). He said that he is very optimistic about the prospects of bipartisan support for the legislation, placing the odds at between 75% and 80% ("Swampland," Time Magazine, 5/21).
generic viagra online
Washington Post Profiles Operation Rescue Founder Randall Terry
The Washington Post on Wednesday profiled Randall Terry, the founder and former head of the antiabortion-rights group Operation Rescue. According to the Post, Terry is known as a "shock jock of the antiabortion movement" with a "theatrical bent." The Post reports that Terry was arrested dozens of times in the late 1980s and 1990s during his protests. For a short period, his "tactics transformed the antiabortion movement," earning him praise from conservative Christian leaders like Jerry Falwell and Pat Robertson. However, after a 1994 federal law made blocking clinics a federal crime, Terry"s group "started to unravel" after he struggled to pay fines for violating the law. He lost in several lawsuits filed by Planned Parenthood -- resulting in him owing $1.6 million to the group -- and he filed for bankruptcy in 1998. Although Terry left as the leader of Operation Rescue in 1991, he now has moved to the Washington, D.C., area to "try to reclaim the prominence he once enjoyed within the antiabortion movement," an effort he is making "much to the consternation of people on both sides of the abortion debate," according to the Post. Most recently, he has been leading protests outside the confirmation hearings for Supreme Court nominee Sonia Sotomayor. The Post reports that leaders in the antiabortion-rights movement "are cringing at Terry"s sudden return," saying that "his incendiary rhetoric and showy tactics turn off ordinary Americans and reflect Terry"s struggle to regain his glory years." He also is focused on starting a new organization, Operation Rescue Insurrecta Nex, a Latin term translated to mean "insurrection against death" (Salmon, Washington Post, 7/15). The Post also included a timeline of Terry"s personal life and history with the antiabortion-rights movement (Washington Post, 7/15).
News of the day
Parasites Ready To Jump
Transposons are mobile genetic elements found in the hereditary material of humans and other organisms. They can replicate and the new copies can insert at novel sites in the genome. Because this threatens the whole organism, molecular mechanisms have evolved which can repress transposon activity. Professor Klaus Förstemann of the Gene Center of Ludwig-Maximilians-Universität (LMU) in Munich and a team of researchers working with the fruitfly Drosophila melanogaster have now uncovered a new type of cellular defence that acts against DNA sequences present in high copy numbers inside the cell, even if they have not integrated into the genome. Small molecules of RNA (a class of nucleic acid closely related to the genetic material DNA) play the central role. "Transposons are genomic parasites, so to speak", says Förstemann. "If they are allowed to proliferate, the genome can become unstable or cancers can develop. We now want to find out whether mammalian cells possess this newly discovered defence mechanism and to elucidate precisely how it works." (EMBO Journal online, 30 July 2009.)
Oncology

Research Team Finds Key Target Of Aging Regulator

Researchers at The Wistar Institute have defined a key target of an evolutionarily conserved protein that regulates the process of aging. The study, published June 11 in Nature, provides fundamental knowledge about key mechanisms of aging that could point toward new anti-aging strategies and cancer therapies. Scientists have long known that a class of proteins called sirtuins promotes fitness and longevity in most organisms ranging from single-celled yeast to mammals. At the cellular level, sirtuins protect genome integrity, enhance resistance to adverse stresses, and antagonize senescence. However, the underlying molecular mechanisms have remained poorly understood. The team, led by senior author Shelley Berger, Ph.D., Hilary Koprowski Professor at The Wistar Institute, demonstrated for the first time a molecular target for a member of this class, Sir2, in regulation of aging in yeast cells. Sir2 removes an acetyl group attached to a specific site (lysine at position 16 or K16) on histone H4 histones are proteins that package and organize the long strands of DNA within the nucleus and also are central regulators in turning genes on and off. The study reveals that removal of this acetyl group by Sir2 near the chromosome ends the telomeres is important for yeast cells to maintain the ability to replicate. Researchers found that Sir2 levels decline as cells age, and there is a concomitant accumulation of the acetylation mark along with disrupted histone organization at telomeres. Deacetylation of H4K16 by Sir2 and consequent telomere stability play a major role in maintaining long lifespan in yeast. Since sirtuins deacetylate many different proteins, these results clarify a key role of Sir2 protein in control of lifespan. "Some modifications on histones, like this acetylation on histone H4 lysine 16, are persistent and are maintained through generations of cell divisions. This DNA-independent inheritance is called epigenetics," Berger says. "Characteristic epigenetic features have been discovered for various developmental processes in recent years. Understanding epigenetic changes associated with aging is a hugely exciting direction in aging research. It will provide insights and ideas not only for new therapies to regulate cells that have lost control of proliferation, such as "immortal" cells found in cancers, but also for new strategies to maintain health and fitness." "We plan to continue to search for new targets of Sir2 and other aging regulators," says lead author Weiwei Dang, Ph.D., a postdoctoral scientist working with Berger. "We are designing unbiased screens for other aging targets and mechanisms in chromatin. Using yeast as our aging model enables us to do many discovery screens that are impossible with other, more complex organisms. Yet it is remarkable that many of these chromatin mechanisms associated with yeast could turn out to be relevant even for aging human cells." Along with senior author Berger and lead author Dang, other authors include: research assistants Rocco Perry and Jean A. Dorsey, from Wistar; graduate student Kristan K. Steffen, Assistant Professor Matt Kaeberlein, Ph.D., and Assistant Professor Brian K. Kennedy, Ph.D., from the University of Washington, Seattle; Assistant Professor F. Brad Johnson, M.D., Ph.D., from the University of Pennsylvania; and Investigator Ali Shilatifard, Ph.D., from the Stowers Institute. This work was funded by the National Institutes of Health and an AFAR Julie Martin Mid-Career Award in Aging Research. The Wistar Institute is an international leader in biomedical research with special expertise in cancer research and vaccine development. Founded in 1892 as the first independent nonprofit biomedical research institute in the country, Wistar has long held the prestigious Cancer Center designation from the National Cancer Institute. Discoveries at Wistar led to the creation of the rubella vaccine that eradicated the disease in the United States, human rabies vaccines used worldwide, and a rotavirus vaccine approved in 2006. Today, Wistar is home to preeminent research programs studying skin cancer, lung cancer, and brain tumors. Wistar Institute Vaccine Center scientists are creating new vaccines against pandemic influenza, HIV, and other diseases threatening global health. The Institute works actively to transfer its inventions to the commercial sector to ensure that research advances move from the laboratory to the clinic as quickly as possible. Wistar Institute


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):